Celldex Therapeutics
CLDX
#4512
Rank
C$3.26 B
Marketcap
C$41.54
Share price
-3.57%
Change (1 day)
42.33%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: C$3.26 Billion

As of May 2026 Celldex Therapeutics has a market cap of C$3.26 Billion. This makes Celldex Therapeutics the world's 4512th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.26 B35.71%
2025C$2.40 B-0.61%
2024C$2.41 B-15.98%
2023C$2.87 B0.99%
2022C$2.84 B23.79%
2021C$2.30 B160.11%
2020C$0.88 B1689.79%
2019C$49.43 M2.23%
2018C$48.35 M-90.04%
2017C$0.48 B0.81%
2016C$0.48 B-77.56%
2015C$2.14 B13.13%
2014C$1.89 B-17.5%
2013C$2.30 B435.6%
2012C$0.42 B267.8%
2011C$0.11 B-11.56%
2010C$0.13 B-15.21%
2009C$0.15 B2.39%
2008C$0.15 B310.9%
2007C$37 M-68.26%
2006C$0.11 B-28.17%
2005C$0.16 B-9.29%
2004C$0.17 B-22.19%
2003C$0.22 B112.66%
2002C$0.10 B-71.99%
2001C$0.38 B-34.39%
2000C$0.58 B243.44%
1999C$0.17 B49.84%
1998C$0.11 B24.01%
1997C$92.23 M108.19%
1996C$44.3 M

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Celldex Therapeutics was reported to be:

C$3.26 Billion
by Nasdaq info icon info icon
C$3.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$198.43 B 5,986.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$240.77 B 7,284.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$138.68 B 4,153.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C$8.42 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$59.31 B 1,719.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.18 B-94.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.57 B-82.32%๐Ÿ‡บ๐Ÿ‡ธ USA